Cargando…
Conventional and emerging treatments of astrocytomas and oligodendrogliomas
PURPOSE: Astrocytomas and oligodendrogliomas are mainly diffuse primary brain tumors harboring a diagnostic and prognostically favorable isocitrate dehydrogenase mutation. They are still incurable besides growing molecular knowledge and therapy options. Circumscribed astrocytomas are also discussed...
Autores principales: | Kessler, Tobias, Ito, Jakob, Wick, Wolfgang, Wick, Antje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226903/ https://www.ncbi.nlm.nih.gov/pubmed/36566461 http://dx.doi.org/10.1007/s11060-022-04216-z |
Ejemplares similares
-
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
Risk factors of extraneural spreading in astrocytomas and oligodendrogliomas in donors with gliomas: A systematic review
por: Ammendola, Serena, et al.
Publicado: (2022) -
Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
por: Kim, Jo-Heon, et al.
Publicado: (2019) -
Immunodetection of Pyruvate Carboxylase Expression in Human Astrocytomas, Glioblastomas, Oligodendrogliomas, and Meningiomas
por: Gondáš, Eduard, et al.
Publicado: (2023) -
Treatment of glioblastoma in adults
por: Wick, Wolfgang, et al.
Publicado: (2018)